Long Term Safety and Efficacy of Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Results from a 36 Week Extension Study.

被引:0
|
作者
Sunkureddi, P. [1 ]
Toth, E. [2 ]
Brown, J. P. [3 ,4 ]
Moericke, R. [5 ]
Richard, D. [6 ]
Lheritier, K. [6 ]
Stancati, A. [6 ]
Kivitz, A. [7 ]
机构
[1] Clear Lake Rheumatol, Nassau Bay, TX USA
[2] Flor Francis Hosp, Dept Rheumatol, Kistarcsa, Hungary
[3] CHU Quebec, Res Ctr, Quebec City, PQ, Canada
[4] Univ Laval, Quebec City, PQ, Canada
[5] Inst Pravent Med & Klin Forsch GbR, Magdeburg, Germany
[6] Novartis Pharma AG, Basel, Switzerland
[7] Altoona Ctr Clin Res, Duncansville, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
174
引用
收藏
页码:S73 / S73
页数:1
相关论文
共 50 条
  • [1] Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Long-Term Safety and Efficacy Results from a 36-Week Extension Study
    Sunkureddi, Prashanth
    Moericke, Ruediger
    Toth, Edith
    Brown, Jacques P.
    Machein, Uwe
    Lheritier, Karine
    Junge, Guido
    Kivitz, Alan J.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] LONG-TERM SAFETY AND MAINTENANCE OF EFFICACY OF CANAKINUMAB LIQUID FORMULATION IN ACUTE GOUTY ARTHRITIS PATIENTS: RESULTS FROM A 36 WEEK EXTENSION STUDY
    Moricke, R.
    Sunkureddi, P.
    Toth, E.
    Brown, J. P.
    Machein, U.
    Lheritier, K.
    Junge, G.
    Kivitz, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1209 - 1210
  • [3] Long-Term Efficacy and Safety of Canakinumab Versus Triamcinolone Acetonide in Acute Gouty Arthritis Patients.
    Brown, J. P.
    So, A.
    Dikranian, A.
    Alten, R.
    Bardin, T.
    Schumacher, H. R.
    Gimona, A.
    Krammer, G.
    Karpov, A.
    Schlesinger, N.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S396 - S396
  • [4] Long-Term Safety of Canakinumab in Patients with Gouty Arthritis.
    So, Alexander
    Alten, Reike
    Schumacher, H. Ralph
    Bloch, Mark
    Bardin, Thomas
    John, Markus R.
    Krammer, Gerhard
    Nebesky, Jan Michael
    Tao, Aiyang
    Schlesinger, Naomi
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S63 - S63
  • [5] Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study
    Buch, Maya H.
    Aletaha, Daniel
    Combe, Bernard G.
    Tanaka, Yoshiya
    Caporali, Roberto
    Schulze-Koops, Hendrik
    Takeuchi, Tsutomu
    Gottenberg, Jacques-Eric
    Blanco, Ricardo
    Verschueren, Patrick
    Zubrzycka-Sienkiewicz, Anna
    De Leonardis, Francesco
    Omoruyi, Edmund V. Ekoka
    Rajendran, Vijay
    Emery, Paul
    RMD OPEN, 2024, 10 (04):
  • [6] Long-Term Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results from a PHASE III Extension Study
    Brunner, Hermine I.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin', Tamas
    Alexeeva, Ekaterina
    Kone-Paut, Isabelle
    Marzan, Katherine
    Wulffraat, Nico
    Schneider, Rayfel
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Vritzali, Eleni
    Lheritier, Karine
    Martinis, Alberto
    Lovell, Daniel J.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] Efficacy of Filgotinib in Patients with Rheumatoid Arthritis: Week 156 Results from a Long-term Extension Study
    Buch, Maya
    Aletaha, Daniel
    Caporali, Roberto F.
    Combe, Bernard G.
    Schulze-Koops, Hendrik
    Gottenberg, Jacques-Eric
    Tanaka, Yoshiya
    Blanco, Ricardo
    Takeuchi, Tsutomu
    Omoruyi, Edmund V. Ekoka
    Van Beneden, Katrien
    Rajendran, Vijay
    Watson, Chris
    De Leonardis, Francesco
    Emery, Paul
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4229 - 4231
  • [8] Efficacy of filgotinib in patients with rheumatoid arthritis: Week 156 results from a long-term extension study
    Buch, Maya H.
    Aletaha, Daniel
    Caporali, Roberto
    Combe, Bernard
    Schulze-Koops, Hendrik
    Gottenberg, Jacques-Eric
    Tanaka, Yoshiya
    Blanco, Ricardo
    Takeuchi, Tsutomu
    Omoruyi, Edmund V. Ekoka
    Van Beneden, Katrien
    Rajendran, Vijay
    Watson, Chris
    De Leonardis, Francesco
    Emery, Paul
    RHEUMATOLOGY, 2024, 63
  • [9] EFFICACY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: WEEK 156 RESULTS FROM A LONG-TERM EXTENSION STUDY
    Buch, Maya H.
    Aletaha, Daniel
    Caporali, Roberto
    Combe, Bernard
    Schulze-Koops, Hendrik
    Gottenberg, Jacques-Eric
    Tanaka, Yoshiya
    Blanco, Ricardo
    Takeuchi, Tsutomu
    Omoruyi, Edmund V. Ekoka
    Van Beneden, Katrien
    Rajendran, Vijay
    Watson, Chris
    De Leonardis, Francesco
    Emery, Paul
    RHEUMATOLOGY, 2024, 63
  • [10] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A SINGLE-CENTER STUDY
    Alexeeva, E.
    Krekhova, E.
    Dvoryakovskaya, T.
    Isaeva, K.
    Chomakhidze, A.
    Chistyakova, E.
    Lomakina, O.
    Denisova, R.
    Mamutova, A.
    Fetisova, A.
    Gautier, M.
    Vankova, D.
    Shingarova, M.
    Kriulin, I.
    Alshevskaya, A.
    Moskalev, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1776 - 1777